SCHEMBL7814901

SCHEMBL7814901

COc1c(Cc2ccccc2)c(=O)c2ccccc2[nH]c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
KDM4E B2RXH2 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
TUBB4A P04350 8/20 0.51
TUBB P07437 8/20 0.51
TUBA3C P0DPH7 8/20 0.51
TUBA1B P68363 8/20 0.51
TUBA4A P68366 8/20 0.51
TUBB4B P68371 8/20 0.51
TUBB3 Q13509 8/20 0.51
TUBB2A Q13885 8/20 0.51
TUBB8 Q3ZCM7 8/20 0.51
TUBA3E Q6PEY2 8/20 0.51
TUBA1A Q71U36 8/20 0.51
TUBA1C Q9BQE3 8/20 0.51
TUBB6 Q9BUF5 8/20 0.51
TUBB2B Q9BVA1 8/20 0.51
TUBB1 Q9H4B7 8/20 0.51
HSD17B10 Q99714 1/20 0.47
CTSV O60911 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811127 0.85 EGFR (0.49) ALDH1A1KDM4ESMN1; SMN2TUBB4ATUBB
SCHEMBL8542367 0.80 KDM4E (0.54) ALDH1A1KDM4ESMN1; SMN2TUBB4ATUBB
SCHEMBL7807575 0.78 ALDH1A1 (0.73) ALDH1A1KDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL7809220 0.76 KDM4E (0.64) ALDH1A1KDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL4065612 0.75 KDM4E (0.72) ALDH1A1KDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL377487 0.75 ALDH1A1 (0.68) ALDH1A1KDM4ESMN1; SMN2HSD17B10MEN1
SCHEMBL31192183 0.75 ALDH1A1 (0.68) ALDH1A1KDM4ESMN1; SMN2HSD17B10MEN1
SCHEMBL8602933 0.75 KDM4E (0.62) ALDH1A1KDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL29045025 0.75 KIF11 (0.62) ALDH1A1KDM4ESMN1; SMN2TUBB4ATUBB
SCHEMBL28813987 0.73 TUBB4A (0.51) ALDH1A1KDM4ESMN1; SMN2TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0644878-B1 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2001-09-12 EP disclosed
US-5712272-A TREATMENT OF NEUROLOGICAL DISORDERS WITH BENZ(B)AZEPINE COMPOUNDS ZENECA LIMITED (GB) 1998-01-27 US disclosed
US-5654295-A NEUROLOGICAL DISORDERS; BENZ(B0AZEPINE COMPOUNDS ZENECA LIMITED (GB) 1997-08-05 US disclosed
US-5492905-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1996-02-20 US disclosed
WO-1993025534-A1 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS ZENECA LIMITED (GB) 1993-12-23 WO disclosed